Prof. Lúcio Lara Santos, MD, Ph.D.

Professor of Surgical Oncology at ICBAS-UP, Head of Experimental Pathology and Therapeutics Group and member of Surgical Oncology Department of IPO-Porto

​

Lúcio José de Lara Santos, MD, PhD, is Professor of Surgical Oncology, Head of Experimental Pathology and Therapeutics Group and member of Surgical Oncology Department of Portuguese Institute of Oncology Francisco Gentil, Porto, Portugal. He also serves as Adviser of Oncology for ONCOCIR - Education and Care in Oncology in Lusophone African Countries and for Ministry of Health in some of them.

Prof. de Lara Santos received MD degrees from both Agostinho Neto University, Angola, and Nova University, Lisboa, Portugal. He received his PhD in Surgery and Oncobiology from Porto University, Porto, Portugal. He served a fellowship in General Surgery at the Portuguese Institute of Oncology. .eceived specialized training in surgical oncology at St. George Hospital in London, esophageal surgery at Leiden Academy and and in liver surgery at Hôpital Paul Brousse in Villejuif, France, and The University of Texas MD Anderson Cancer Center in Houston, Texas.

Prof. de Lara Santos’ research interests include surgical oncology and carcinogenesis, working in Portugal and Lusophone African Countries, particularly in Angola. As a Consultant Surgical Oncologist and General Surgeon in the Portuguese Institute of Oncology (GI and Breast Cancer Unit), Prof. de Lara Santos conducts research in experimental pathology and oncology, including GI, breast cancer, and cancers related to infections. He has extensive experience in organizing oncology facilities such as chemotherapy, radiation therapy, and surgical oncology services, and in standardizing procedures and teaching of general medicine, surgery, and oncology.
Additionally, Prof. de Lara Santos is the author or coauthor of nearly 140 peer-reviewed publications in journals including Anticancer Research, Annals of Oncology, BMC Cancer, International Journal of Oncology, Nature Communication, British Journal of Cancer, and Molecular Oncology and book chapters and two book of oral and breast oncology.